Reinforcing breath carbon monoxide reductions in chronic obstructive pulmonary disease
- PMID: 1797517
- DOI: 10.1016/0376-8716(91)90021-p
Reinforcing breath carbon monoxide reductions in chronic obstructive pulmonary disease
Abstract
Chronic Obstructive Pulmonary Disease (COPD) usually results from tobacco smoking. Smoking cessation slows COPD's progression, but few have studied anti-smoking treatments in COPD. In 3-month trials we paid lottery tickets during daily home visits to still-smoking COPD patients for reductions in breath carbon monoxide (CO), a measure of smoke intake. In our first protocol experimental patients received 0-3 tickets per day, depending upon the extent of CO reduction below pre-treatment baselines; yoked controls received the same number of tickets, but not contingent on CO. The protocol produced no change. In a second study patients were assigned a post-baseline quit-date, received nicotine gum, and were paid up to 5 tickets per night, but only for CO less than 10 parts per million (ppm). CO fell sharply as the intervention began, but gradually rose again. A third protocol added special reinforcement schedules for those who did not quit or relapsed (up to 20 tickets per night for CO less than 10 ppm). Daily CO concentrations fell from 27.1 parts per million (baseline mean) to 12.7 (intervention mean), but rapid increases followed the intervention. Few patients stopped smoking, but CO and cigarettes used per day significantly fell during Studies 2 and 3. Post-hoc analysis suggested only a small effect from gum.
Similar articles
-
Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients.Psychopharmacology (Berl). 1995 May;119(2):193-204. doi: 10.1007/BF02246161. Psychopharmacology (Berl). 1995. PMID: 7659767 Clinical Trial.
-
Carbon monoxide assessment of smoking in chronic obstructive pulmonary disease.Addict Behav. 1989;14(5):493-502. doi: 10.1016/0306-4603(89)90069-5. Addict Behav. 1989. PMID: 2589127
-
Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study.Clin Pharmacol Ther. 2005 Dec;78(6):689-96. doi: 10.1016/j.clpt.2005.08.019. Clin Pharmacol Ther. 2005. PMID: 16338284 Clinical Trial.
-
Chemical analyses as validators in smoking cessation programs.J Behav Med. 1993 Jun;16(3):295-308. doi: 10.1007/BF00844761. J Behav Med. 1993. PMID: 8350343 Review.
-
Use of Expired Air Carbon Monoxide Testing in Clinical Tobacco Treatment Settings.Chest. 2018 Feb;153(2):554-562. doi: 10.1016/j.chest.2017.11.002. Epub 2017 Nov 11. Chest. 2018. PMID: 29137909 Review.
Cited by
-
A New Frontier: Integrating Behavioral and Digital Technology to Promote Health Behavior.Behav Anal. 2014 Aug 23;38(1):19-49. doi: 10.1007/s40614-014-0017-y. eCollection 2015 May. Behav Anal. 2014. PMID: 27347477 Free PMC article.
-
Effects of an Internet-based voucher reinforcement program for smoking abstinence: a feasibility study.J Appl Behav Anal. 2005 Fall;38(3):349-57. doi: 10.1901/jaba.2005.150-04. J Appl Behav Anal. 2005. PMID: 16270844 Free PMC article.
-
Effects of internet-based voucher reinforcement and a transdermal nicotine patch on cigarette smoking.J Appl Behav Anal. 2007 Spring;40(1):1-13. doi: 10.1901/jaba.2007.40-1. J Appl Behav Anal. 2007. PMID: 17471790 Free PMC article. Clinical Trial.
-
Incentives for smoking cessation.Cochrane Database Syst Rev. 2019 Jul 17;7(7):CD004307. doi: 10.1002/14651858.CD004307.pub6. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2025 Jan 13;1:CD004307. doi: 10.1002/14651858.CD004307.pub7. PMID: 31313293 Free PMC article. Updated.
-
An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar.J Appl Behav Anal. 1996 Winter;29(4):495-504; quiz 504-5. doi: 10.1901/jaba.1996.29-495. J Appl Behav Anal. 1996. PMID: 8995832 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical